Literature DB >> 23759235

[Economic burden and related factors on inpatients with HBV-related diseases in Shandong province].

Jing-jing Lü1, Ren-peng Li, Ai-qiang Xu, Li Zhang, Li-zhi Song, Bing-yu Yan, Feng Ji, Jia-ye Liu, Xue-qiang Fang, Zhen Wang, Da-wei Zhu, Guo-Jie Zhang, Yi Feng, Zuo-kui Xiao, Jian Wang.   

Abstract

OBJECTIVE: To investigate the economic burden of patients with acute and chronic hepatitis B, cirrhosis and liver cancer caused by hepatitis B virus (HBV).
METHODS: Cluster sampling was used on cases consecutively collected during the study period. Questionnaire survey was conducted and information on the expenses during hospitalization was collected from the hospital records and through interviewing those patients.
RESULTS: Yearly costs related to patients with acute hepatitis B, severe hepatitis B, chronic hepatitis B, cirrhosis, hepatocellular carcinoma were 66.7, 138.1, 127.4, 151.7 and 377.2 thousand Yuan, respectively.
RESULTS: from multiple linear regression model showed that the type of medical insurance scheme, annual days of hospitalization, classifications of HBV-related diseases and personal income were major influencing factors on the cost.
CONCLUSION: HBV infection caused considerable burden to families and the society, indicating that HBV infection control programs would bring huge potential benefits. The reform of insurance scheme should be administrated to promote social fairness.

Entities:  

Mesh:

Year:  2013        PMID: 23759235

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree.

Authors:  Nan Yang; Lei Lei; Yiyu Meng; Naitong Zhou; Lizheng Shi; Ming Hu
Journal:  Front Public Health       Date:  2022-06-21

2.  No expenditure difference among patients with liver cancer at stage I-IV: Findings from a multicenter cross-sectional study in China.

Authors:  Haike Lei; Lin Lei; Jufang Shi; Yongzhong Wu; Ling Liang; Huiyao Huang; Mei He; Fangzhou Bai; Maomao Cao; Hui Qiu; Yuting Wang; Chengcheng Liu; Jia Du; Hong Wang; Yan Zhang; Mengdi Cao; Ji Peng; Ni Li; Chunfeng Qu; Min Dai; Wanqing Chen; Jie He
Journal:  Chin J Cancer Res       Date:  2020-08       Impact factor: 4.026

Review 3.  Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges.

Authors:  Yong-Ping Yan; Hai-Xia Su; Zhao-Hua Ji; Zhong-Jun Shao; Zhong-Shu Pu
Journal:  J Clin Transl Hepatol       Date:  2014-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.